Related Experiment Video
Updated: Jun 26, 2026

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
[Recent advances in studies of clinical treatment of uveitis]
1Tianjin Eye Hospital, Clinical College of Ophthalmology, Tianjin Medical University, Tianjin 300020, China. eye2002@163.com
Uveitis is a common immune-related intraocular inflammation, the topical or systemic corticosteroids are the first-line drugs for the treatment of uveitis. The combined immunomodulatory agents of cyclosporine, mycophenolate mofetil, azathioprine or cyclophosphamide are helpful for the treatment of severe or refractory uveitis. The new biologic agents, tumor necrosis factor inhibitors, interferon alpha or the interleukin-2 receptor antagonists, are also helpful for certain types of refractory uveitis. Intravitreal steroids injection or vitrectomy would be beneficial for specific types of uveitis and their complications. The advances of uveitis treatment in recent years are reviewed.
Uveitis is a common immune-related intraocular inflammation, the topical or systemic corticosteroids are the first-line drugs for the treatment of uveitis. The combined immunomodulatory agents of cyclosporine, mycophenolate mofetil, azathioprine or cyclophosphamide are helpful for the treatment of severe or refractory uveitis. The new biologic agents, tumor necrosis factor inhibitors, interferon alpha or the interleukin-2 receptor antagonists, are also helpful for certain types of refractory uveitis. Intravitreal steroids injection or vitrectomy would be beneficial for specific types of uveitis and their complications. The advances of uveitis treatment in recent years are reviewed.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Nephrotic Syndrome II : Assessment and Medical Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Clinical Trials
There are four phases in a clinical trial. A phase one...
